{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:43:47Z","timestamp":1794685427455,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Accurate detection of unconventional histologies (UH) in prostate cancer (PCa) is crucial for treatment planning and prognosis.<\/jats:p>\n                    <jats:p>This systematic review and meta-analysis aimed to evaluate the accuracy of multiparametric magnetic resonance imaging (mpMRI) in detecting UH on prostatectomy, particularly cribriform architecture (CA) and intraductal carcinoma (IDC-P), in patients with localized PCa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted in major databases for studies published after 2000. Seventeen articles fulfilled the inclusion criteria and were eligible for qualitative analysis. Five studies met the inclusion criteria for meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pooled sensitivity and specificity of mpMRI (Prostate Imaging Reporting and Data System (PI-RADS) cutoff 3) to detect cribriform architecture were 0.91 and 0.29. The proportion of cribriform lesions increased with higher PI-RADS scores (23.2% for PI-RADS 1-2 to 66.7% for PI-RADS 5). For intraductal carcinoma (IDC-P), two studies found that IDC-P lesions were visible on mpMRI and had lower apparent diffusion coefficient (ADC) values compared to acinar prostate cancer. Four studies evaluating combined CA\/IDC-P found sensitivities ranging from 33 to 100%. Lower ADC values were associated with CA\/IDC-P in some studies, but not in others. Overall, mpMRI demonstrated promising sensitivity but moderate specificity in detecting these aggressive histological variants, with continued challenges in accurate sampling and characterization of mpMRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>mpMRI shows high sensitivity but moderate specificity in detecting cribriform architecture in PCa, especially for high PI-RADS scores. These findings support the use of mpMRI for UH detection, but caution is advised in clinical interpretation. Larger prospective studies are needed to validate these results before routine clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient summary<\/jats:title>\n                    <jats:p>We studied how effective MRI is at identifying different UH of PCa, such as cribriform architecture and intraductal carcinoma. MRI is accurate at detecting these cancers when they are present, but it also produces a significant number of false positives. More research is needed to standardize imaging protocols and histological definition and ensure an accurate diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>The accurate detection of unconventional histologies in prostate cancer, particularly cribriform architecture and intraductal carcinoma, is challenging but crucial for treatment planning and prognosis.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>mpMRI shows high sensitivity (91%) but low specificity (29%) for detecting cribriform architecture, with detection rates increasing proportionally with higher PI-RADS scores.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>mpMRI can effectively detect aggressive unconventional histologies in prostate cancer, though its moderate specificity suggests the need for careful interpretation. This aids in risk stratification and treatment planning, potentially improving patient outcomes.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-11603-3","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:15:44Z","timestamp":1746170144000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Filippo","family":"Carletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Preisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo F. W.","family":"Soeterik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Prad\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio Dal","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C. N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-373X","authenticated-orcid":false,"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EAU-YAU Prostate Cancer Working Party","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"11603_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/CAAC.21660","journal-title":"CA Cancer J Clin"},{"key":"11603_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.EURURO.2023.03.014","volume":"84","author":"G Marra","year":"2023","unstructured":"Marra G, van Leenders GJLH, Zattoni F et al (2023) Impact of epithelial histological types, subtypes, and growth patterns on oncological outcomes for patients with nonmetastatic prostate cancer treated with curative intent: a systematic review. Eur Urol 84:65\u201385. https:\/\/doi.org\/10.1016\/J.EURURO.2023.03.014","journal-title":"Eur Urol"},{"key":"11603_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMOA1801993\/SUPPL_FILE\/NEJMOA1801993_DISCLOSURES.PDF","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777. https:\/\/doi.org\/10.1056\/NEJMOA1801993\/SUPPL_FILE\/NEJMOA1801993_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"11603_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.EURURO.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2. Eur Urol 69:16\u201340. https:\/\/doi.org\/10.1016\/J.EURURO.2015.08.052","journal-title":"Eur Urol"},{"key":"11603_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/J.EURURO.2022.07.002","volume":"82","author":"GJ Netto","year":"2022","unstructured":"Netto GJ, Amin MB, Berney DM et al (2022) The 2022 World Health Organization classification of tumors of the urinary system and male genital organs\u2014Part B: Prostate and urinary tract tumors. Eur Urol 82:469\u2013482. https:\/\/doi.org\/10.1016\/J.EURURO.2022.07.002","journal-title":"Eur Urol"},{"key":"11603_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","volume":"45","author":"TH van der Kwast","year":"2021","unstructured":"van der Kwast TH, van Leenders GJ, Berney DM et al (2021) ISUP consensus definition of cribriform pattern prostate cancer. Am J Surg Pathol 45:1118\u20131126. https:\/\/doi.org\/10.1097\/PAS.0000000000001728","journal-title":"Am J Surg Pathol"},{"key":"11603_CR7","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","volume":"50","author":"D Trudel","year":"2014","unstructured":"Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, Van Der Kwast TH (2014) Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. Eur J Cancer 50:1610\u20131616. https:\/\/doi.org\/10.1016\/j.ejca.2014.03.009","journal-title":"Eur J Cancer"},{"key":"11603_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/HIS.14658","volume":"80","author":"LL Rijstenberg","year":"2022","unstructured":"Rijstenberg LL, Hansum T, Kweldam CF et al (2022) Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies. Histopathology 80:1041. https:\/\/doi.org\/10.1111\/HIS.14658","journal-title":"Histopathology"},{"key":"11603_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","volume":"32","author":"E Hollemans","year":"2019","unstructured":"Hollemans E, Verhoef EI, Bangma CH et al (2019) Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Mod Pathol 32:139\u2013146. https:\/\/doi.org\/10.1038\/s41379-018-0157-9","journal-title":"Mod Pathol"},{"key":"11603_CR10","unstructured":"Amin MB (2022) Urinary and male genital tumours. WHO Classification of Tumours Editorial Board, Lyon"},{"key":"11603_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/modpathol.2014.116","volume":"28","author":"CF Kweldam","year":"2015","unstructured":"Kweldam CF, Wildhagen MF, Steyerberg EW, Bangma CH, Van Der Kwast TH, Van Leenders GJLH (2015) Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol 28:457\u2013464. https:\/\/doi.org\/10.1038\/modpathol.2014.116","journal-title":"Mod Pathol"},{"key":"11603_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00428-015-1809-5","volume":"467","author":"DT Keefe","year":"2015","unstructured":"Keefe DT, Schieda N, El Hallani S et al (2015) Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy. Virchows Arch 467:437\u2013442. https:\/\/doi.org\/10.1007\/s00428-015-1809-5","journal-title":"Virchows Arch"},{"key":"11603_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","volume":"20","author":"JE McNeal","year":"1996","unstructured":"McNeal JE, Yemoto CEM (1996) Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 20:802\u2013814. https:\/\/doi.org\/10.1097\/00000478-199607000-00003","journal-title":"Am J Surg Pathol"},{"key":"11603_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0046-8177(98)90423-3","volume":"29","author":"G Wilcox","year":"1998","unstructured":"Wilcox G, Soh S, Chakraborty S, Scardino PT, Wheeler TM (1998) Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol 29:1119\u20131123. https:\/\/doi.org\/10.1016\/S0046-8177(98)90423-3","journal-title":"Hum Pathol"},{"key":"11603_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/J.1464-410X.1998.00530.X","volume":"81","author":"RJ Cohen","year":"1998","unstructured":"Cohen RJ, Chan WC, Edgar SG et al (1998) Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma. Br J Urol 81:413\u2013418. https:\/\/doi.org\/10.1046\/J.1464-410X.1998.00530.X","journal-title":"Br J Urol"},{"key":"11603_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/PAS.0000000000001678","volume":"45","author":"KA Iczkowski","year":"2021","unstructured":"Iczkowski KA, Van Leenders GJLH, Van Der Kwast TH (2021) The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol 45:1005\u20131007. https:\/\/doi.org\/10.1097\/PAS.0000000000001678","journal-title":"Am J Surg Pathol"},{"key":"11603_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/arpa.2020-0015-ra","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein JI, Amin MB, Fine SW et al (2021) The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer. Arch Pathol Lab Med 145:461\u2013493. https:\/\/doi.org\/10.5858\/arpa.2020-0015-ra","journal-title":"Arch Pathol Lab Med"},{"key":"11603_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.juro.2018.01.081","volume":"200","author":"S Prendeville","year":"2018","unstructured":"Prendeville S, Gertner M, Maganti M et al (2018) Role of magnetic resonance imaging targeted biopsy in detection of prostate cancer harboring adverse pathological features of intraductal carcinoma and invasive cribriform carcinoma. J Urol 200:104\u2013113. https:\/\/doi.org\/10.1016\/j.juro.2018.01.081","journal-title":"J Urol"},{"key":"11603_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1148\/RADIOL.10091343","volume":"255","author":"DL Langer","year":"2010","unstructured":"Langer DL, van der Kwast TH, Evans AJ et al (2010) Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 255:485\u2013494. https:\/\/doi.org\/10.1148\/RADIOL.10091343","journal-title":"Radiology"},{"key":"11603_CR20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/JMRI.25716","volume":"46","author":"O Helfrich","year":"2017","unstructured":"Helfrich O, Puech P, Betrouni N et al (2017) Quantified analysis of histological components and architectural patterns of Gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations. J Magn Reson Imaging 46:1786\u20131796. https:\/\/doi.org\/10.1002\/JMRI.25716","journal-title":"J Magn Reson Imaging"},{"key":"11603_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.22037\/uj.v19i.7382","volume":"20","author":"MB Tuna","year":"2023","unstructured":"Tuna MB, Arslan A, K\u00f6k YB et al (2023) Cribriform pattern of the prostate adenocarcinoma: sensitivity of multiparametric MRI. Urol J 20:34\u201340. https:\/\/doi.org\/10.22037\/uj.v19i.7382","journal-title":"Urol J"},{"key":"11603_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/JRSM.1439","volume":"12","author":"A Patel","year":"2021","unstructured":"Patel A, Cooper N, Freeman S, Sutton A (2021) Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta-analysis of diagnostic test accuracy data. Res Synth Methods 12:34\u201344. https:\/\/doi.org\/10.1002\/JRSM.1439","journal-title":"Res Synth Methods"},{"key":"11603_CR23","doi-asserted-by":"crossref","unstructured":"Green S, Higgins JPT, Alderson P, Clarke M, Mulrow CD, Oxman AD (2008) Chapter1: Introduction. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Chichester","DOI":"10.1002\/9780470712184.ch1"},{"key":"11603_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/BJU.14640","volume":"123","author":"M Assel","year":"2019","unstructured":"Assel M, Sjoberg D, Elders A et al (2019) Guidelines for reporting of statistics for clinical research in urology. BJU Int 123:401\u2013410. https:\/\/doi.org\/10.1111\/BJU.14640","journal-title":"BJU Int"},{"key":"11603_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","volume":"13","author":"C Tufanaru","year":"2015","unstructured":"Tufanaru C, Munn Z, Stephenson M, Aromataris E (2015) Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 13:196\u2013207. https:\/\/doi.org\/10.1097\/XEB.0000000000000065","journal-title":"Int J Evid Based Healthc"},{"key":"11603_CR26","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/SIM.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, \u00d6zdemir P (2010) Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med 29:3046\u20133067. https:\/\/doi.org\/10.1002\/SIM.4040","journal-title":"Stat Med"},{"key":"11603_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/J.JCLINEPI.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982\u2013990. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2005.02.022","journal-title":"J Clin Epidemiol"},{"key":"11603_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","volume":"59","author":"H Chu","year":"2006","unstructured":"Chu H, Cole SR (2006) Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 59:1331\u20131332. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.06.011","journal-title":"J Clin Epidemiol"},{"key":"11603_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/JRSM.1283","volume":"9","author":"DL Burke","year":"2018","unstructured":"Burke DL, Ensor J, Snell KIE, van der Windt D, Riley RD (2018) Guidance for deriving and presenting percentage study weights in meta-analysis of test accuracy studies. Res Synth Methods 9:163\u2013178. https:\/\/doi.org\/10.1002\/JRSM.1283","journal-title":"Res Synth Methods"},{"key":"11603_CR30","doi-asserted-by":"publisher","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.D4002","DOI":"10.1136\/BMJ.D4002"},{"key":"11603_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"11603_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.juro.2017.01.077","volume":"198","author":"M Truong","year":"2017","unstructured":"Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP (2017) Impact of Gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging: correlation with final histopathology. J Urol 198:316\u2013321. https:\/\/doi.org\/10.1016\/j.juro.2017.01.077","journal-title":"J Urol"},{"key":"11603_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00259-019-04320-9","volume":"46","author":"J Gao","year":"2019","unstructured":"Gao J, Zhang C, Zhang Q et al (2019) Diagnostic performance of 68Ga-PSMA PET\/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections. Eur J Nucl Med Mol Imaging 46:1531\u20131541. https:\/\/doi.org\/10.1007\/s00259-019-04320-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11603_CR34","doi-asserted-by":"publisher","first-page":"452.e1","DOI":"10.1016\/j.urolonc.2022.07.012","volume":"40","author":"Q Cai","year":"2022","unstructured":"Cai Q, Costa DN, Metter CK et al (2022) Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (cribriform Gleason pattern 4 and intraductal carcinoma): correlation of detected and missed prostate cancer foci with whole mount histopathology. Urol Oncol 40:452.e1\u2013452.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2022.07.012","journal-title":"Urol Oncol"},{"key":"11603_CR35","doi-asserted-by":"publisher","unstructured":"Arslan A, Alis D, Tuna MB, Sa\u011fl\u0131can Y, Kural AR, Karaarslan E (2021) The visibility of prostate cancer concerning underlying histopathological variances: a single-center multiparametric magnetic resonance imaging study. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109791","DOI":"10.1016\/j.ejrad.2021.109791"},{"key":"11603_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/bju.14812","volume":"124","author":"PP Tonttila","year":"2019","unstructured":"Tonttila PP, Ahtikoski A, Kuisma M, P\u00e4\u00e4kk\u00f6 E, Hirvikoski P, Vaarala MH (2019) Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer. BJU Int 124:992\u2013998. https:\/\/doi.org\/10.1111\/bju.14812","journal-title":"BJU Int"},{"key":"11603_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.juro.2017.07.037","volume":"199","author":"M Truong","year":"2018","unstructured":"Truong M, Feng C, Hollenberg G et al (2018) A comprehensive analysis of cribriform morphology on magnetic resonance imaging\/ultrasound fusion biopsy correlated with radical prostatectomy specimens. J Urol 199:106\u2013113. https:\/\/doi.org\/10.1016\/j.juro.2017.07.037","journal-title":"J Urol"},{"key":"11603_CR38","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/jmri.24694","volume":"41","author":"N Coffey","year":"2015","unstructured":"Coffey N, Schieda N, Cron G, Gulavita P, Mai KT, Flood TA (2015) Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma. J Magn Reson Imaging 41:1639\u20131645. https:\/\/doi.org\/10.1002\/jmri.24694","journal-title":"J Magn Reson Imaging"},{"key":"11603_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bju.15093","volume":"126","author":"CK Mannaerts","year":"2020","unstructured":"Mannaerts CK, Engelbrecht MRW, Postema AW et al (2020) Detection of clinically significant prostate cancer in biopsy-na\u00efve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy. BJU Int 126:481\u2013493. https:\/\/doi.org\/10.1111\/bju.15093","journal-title":"BJU Int"},{"key":"11603_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/jmri.26594","volume":"50","author":"S Currin","year":"2019","unstructured":"Currin S, Flood TA, Krishna S, Ansari A, McInnes MDF, Schieda N (2019) Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers. J Magn Reson Imaging 50:279\u2013287. https:\/\/doi.org\/10.1002\/jmri.26594","journal-title":"J Magn Reson Imaging"},{"key":"11603_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/his.13747","volume":"74","author":"M Masoomian","year":"2019","unstructured":"Masoomian M, Downes MR, Sweet J et al (2019) Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Histopathology 74:474\u2013482. https:\/\/doi.org\/10.1111\/his.13747","journal-title":"Histopathology"},{"key":"11603_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.212163","volume":"305","author":"S Ghai","year":"2022","unstructured":"Ghai S, Perlis N, Atallah C et al (2022) Comparison of micro-US and multiparametric MRI for prostate cancer detection in biopsy-naive men. Radiology 305:390\u2013398. https:\/\/doi.org\/10.1148\/radiol.212163","journal-title":"Radiology"},{"key":"11603_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/pros.24291","volume":"82","author":"A Mikoshi","year":"2022","unstructured":"Mikoshi A, Miyai K, Hamabe F et al (2022) MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern. Prostate 82:452\u2013463. https:\/\/doi.org\/10.1002\/pros.24291","journal-title":"Prostate"},{"key":"11603_CR44","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/his.13893","volume":"75","author":"E Hollemans","year":"2019","unstructured":"Hollemans E, Verhoef EI, Bangma CH et al (2019) Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens. Histopathology 75:338\u2013345. https:\/\/doi.org\/10.1111\/his.13893","journal-title":"Histopathology"},{"key":"11603_CR45","doi-asserted-by":"publisher","first-page":"48.e11","DOI":"10.1016\/j.urolonc.2022.09.025","volume":"41","author":"G Pahouja","year":"2023","unstructured":"Pahouja G, Patel HD, Desai S et al (2023) The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: diagnostic accuracy of biopsy, MRI-visibility, and outcomes. Urol Oncol 41:48.e11\u201348.e18. https:\/\/doi.org\/10.1016\/j.urolonc.2022.09.025","journal-title":"Urol Oncol"},{"key":"11603_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2022.02.021","volume":"82","author":"A Ng","year":"2022","unstructured":"Ng A, Khetrapal P, Kasivisvanathan V (2022) Is it PRIME time for biparametric magnetic resonance imaging in prostate cancer diagnosis? Eur Urol 82:1\u20132. https:\/\/doi.org\/10.1016\/j.eururo.2022.02.021","journal-title":"Eur Urol"},{"key":"11603_CR47","doi-asserted-by":"publisher","first-page":"e070280","DOI":"10.1136\/bmjopen-2022-070280","volume":"13","author":"A Asif","year":"2023","unstructured":"Asif A, Nathan A, Ng A et al (2023) Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open 13:e070280. https:\/\/doi.org\/10.1136\/bmjopen-2022-070280","journal-title":"BMJ Open"},{"key":"11603_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41391-019-0158-x","volume":"23","author":"KK Porter","year":"2020","unstructured":"Porter KK, King A, Galgano SJ, Sherrer RL, Gordetsky JB, Rais-Bahrami S (2020) Financial implications of biparametric prostate MRI. Prostate Cancer Prostatic Dis 23:88\u201393. https:\/\/doi.org\/10.1038\/s41391-019-0158-x","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"11603_CR49","doi-asserted-by":"publisher","unstructured":"de Rooij M, Allen C, Twilt JJ et al (2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-10795-4","DOI":"10.1007\/s00330-024-10795-4"},{"key":"11603_CR50","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25:879\u2013887. https:\/\/doi.org\/10.1016\/S1470-2045(24)00220-1","journal-title":"Lancet Oncol"},{"key":"11603_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.euo.2023.06.013","volume":"6","author":"L Lenfant","year":"2023","unstructured":"Lenfant L, Seisen T, Roupr\u00eat M, Pinar U, Mozer PC (2023) Unleashing the power of artificial intelligence and fusion magnetic resonance imaging-targeted biopsy: transforming prostate cancer diagnosis. Eur Urol Oncol 6:541\u2013542. https:\/\/doi.org\/10.1016\/j.euo.2023.06.013","journal-title":"Eur Urol Oncol"},{"key":"11603_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/JU.0000000000000526","volume":"203","author":"KJ Ericson","year":"2020","unstructured":"Ericson KJ, Wu SS, Lundy SD, Thomas LJ, Klein EA, McKenney JK (2020) Diagnostic accuracy of prostate biopsy for detecting cribriform Gleason pattern 4 carcinoma and intraductal carcinoma in paired radical prostatectomy specimens: implications for active surveillance. J Urol 203:311\u2013317. https:\/\/doi.org\/10.1097\/JU.0000000000000526","journal-title":"J Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11603-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T14:03:36Z","timestamp":1765980216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["11603"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11603-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Fabio Zattoni, MD, PhD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"F.G. is a member of the Scientific Editorial Board of\n                      European Radiology\n                      (section: Urogenital). As such, they did not participate in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it constitutes a systematic review.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously documented in association with this systematic review.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}